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Abstract
Objectives: The aim of this studywas to compare the effectiveness of using Ping On ointment and using petroleum
jelly in the treatment of temporomandibular joint (TMJ) andmasticatory muscle pain, in order to establish the true
efficacy of Ping On ointment.
Methods: In this randomized, double-blinded, placebo-controlled trial, 55 subjects with TMJ and=or masticatory
pain (Group I patients according to the Research Diagnostic Criteria for Temporomandibular Disorder (RDC=
TMD) received Ping On ointment for 4 weeks, or placebo for 4 weeks. Subjects were evaluated with standard
measures of efficacy: pain intensity measured by visual analogue scale and maximal comfortable mandibular
opening, at baseline and again after 4 weeks of treatment.
Results: Ping On ointment significantly reduced the symptoms of painful TMJs and=or masticatory muscles.
Maximal comfortable mandibular opening also improved in the Ping On ointment group compared with the
placebo, but was not clinically significant.
Conclusions: This preliminary study suggests that topical application of Ping On ointment may be considered for
further investigation as a potential first-line treatment modality, before prescribing analgesics, for the manage-
ment of TMDs. It is topically applied, safe, reversible, and effective in managing TMDs and masticatory muscle
pain.
Introduction
Temporomandibular disorders (TMDs) is a collectiveterm that includes a number of clinical diagnoses in-
volving the temporomandibular joints (TMJs), the mastica-
tory musculature, and associated structures or both excluding
pain of dental origin.1
TMDs are frequently encountered in general clinical prac-
tice, and their prevalence in the general population has been
reported as being as high as 12%.2 Pain can be present any
stage of TMDs and is a significant part of the symptoms that
prompt patients to seek treatment.3
Treatments for TMDs are wide-ranging and directed pri-
marily toward relief from persistent orofacial pain. Up to
now, most TMDs have been treated by conservative treat-
ments such as counseling, physiotherapy, splint therapy, and
prescription of analgesics. Anti-inflammatory or analgesic
medications—in particular, nonsteroidal anti-inflammatory
drugs (NSAIDs) and nonselective cyclo-oxygenase inhibitors—
are frequently used to manage TMDs.4–6 However, no treat-
ments are considered completely effective and able to
produce definite long-term pain relief. Therefore, patients
with TMD pain usually report serious suffering and anxi-
ety even when receiving treatment, which can last long peri-
ods and involve complicated procedures such as construction
of occlusal splints, while not offering much promise. Given
the prevalence of TMDs, safety concerns with chronic NSAID
administration, and the controversial effectiveness of non-
pharmacologic therapies such as TMJ surgery, splints, and
occlusal alteration, new treatment modalities for TMDs are
continually being sought.
Topical application of medicinal creams is one of the
treatment alternatives drawing increasing attention. Topical
application of capsaicin cream (Theraflex-TMJ cream, Sagmel
Inc., IL),NSAIDs, and indomethacinphonophoresis havebeen
shown to be effective in various studies.7–10
Chinese orthopedics is a field of Traditional Chinese
Medicine (TCM) that has been used in the Chinese population
for the treatment of bone, joint, and muscle diseases for sev-
eral thousand years. One of the methods for treatment of
musculoskeletal pain is local massage with topical Chinese
medicinal herbs ointment, such as Ping On ointment.11
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Ping On ointment (Ping On Ointment Company Limited,
Hong Kong) is a licensed topical medicinal ointment of which
the main ingredients are natural Chinese medicinal herbs. It
has been registered in Hong Kong since 1965 and has been
used extensively as a soothing massage balm for muscular
aches, strain, and sprain. The main ingredients of Ping On
ointment, according to the manufacturer, include peppermint
oil, 18%; menthol, 20%; natural camphor, 6%; birch oil, 6%;
sandalwood oil, 1%; eucalyptus oil, 4%; bee wax, 8%; and
aromatic oil, 3%. It does not contain antibiotics, steroids,
cortisone, or preservatives. If topical application of the oint-
ment can be effective for decreasing the severity of TMD
muscular pain, it could be endorsed as a new alternative for
treating TMD muscular pain.
Our group published a case study of five consecutive cases
using Ping On ointment to treat TMD muscular pain.11 All
cases resulted in complete remission of painwithin 1month of
topical massage. They concluded that this treatment method
had high potential to benefit a significant number of people
and that randomized controlled trials should be performed.
Materials and Methods
Aim and objective
The aim of the study is to compare the effectiveness of
using Ping On ointment and using petroleum jelly in the
treatment of TMJ and masticatory muscle pain (Group I
patients according to the Research Diagnostic Criteria for
Temporomandibular Disorder (RDC=TMD),12 in order to
establish the true efficacy of Ping On ointment.
The null hypothesis states that there is no significant im-
provement in pain relief in patients receiving Ping On oint-
ment compared with those receiving petroleum jelly.
The study was a randomized, double-blinded, placebo-
controlled clinical trial. The CONSORT statement was used
as guidance to ensure the quality of the study.13
Study population
Ethicalapprovalwasobtained fromthe InstitutionalReview
Board of the University of Hong Kong=Hospital Authority
Hong Kong West Cluster. The appropriate subjects were
identified and recruited from specialist clinics and were also
recruited from the public using newspaper advertising. In
the latter case, all recruited subjects were referred to appro-
priate specialist departments for consultation if any doubt
existed about the diagnosis or any pathology other than TMJ
muscular pain suspected. The nature, aim, procedures, and
possible risks and benefits of the study were explained to the
eligible subjects. Both verbal and written informed consents
were obtained prior to the screening. All of the subjects were
referred to appropriate specialist departments for follow-up
after the project upon their request.
Inclusion criteria
The inclusion criteria were the following.
1. Positive clinical diagnosis of Group I (muscle disorders)
of TMDs. The TMD diagnosis is classified using axis I of
the Research Diagnostic Criteria (RDC) for TMDs.12
Muscle disorders include both painful and nonpainful
disorders. This classification deals only with the most
common painful disorders associated with TMDs.
2. For joint and muscle pain complaint, subjects were re-
quired to self-report of at least 1 month of daily or nearly
daily pain.
3. Subjects with myogenic pain were included if they met
inclusion and exclusion criteria since patientswith TMDs
are known to exhibit muscle pain secondary to their
joint dysfunction.
Exclusion criteria
The exclusion criteria were the following.
1. Subjects with infectious arthritis, crystal-induced arth-
ropathies, musculoskeletal disorders, subjects with a
primary diagnosis of myofascial pain based on the RDC.
2. Subjects with pain attributable to confirmed migraine or
head pain condition other than tension headache.
3. Subjects with acute infection or other significant disease
of teeth, ears, eyes, nose, or throats; subjects with un-
treated depressive disorder or not on stable antide-
pressant medication for more than 6 months.
4. Subjects with dental diseases that required ongoing
treatment, which would confound the evaluation of
orofacial pain.
5. Subjects who are not competent in giving consents.
6. Pregnant or lactating women.
7. Subjects with sensitivity to the ingredients of Ping On
ointment were excluded.
Patients who met the inclusion criteria were informed
about the study design and advised that they had equal op-
portunity of receiving experimental ointment or the placebo
ointment without knowing until the trial had ended. They
were informed that they could stop participating in the study
at any time without any prejudice. A written informed con-
sent was obtained by each patient who entered the trial.
Sixty-three (63) subjects were screened in total, and 55
patients met the inclusion criteria and were recruited. The
screening consisted of medical history, questionnaire, and
clinical examination as baseline record. The questionnaire and
clinical examination followed the format of the RDC=TMD
booklet.12
Study protocol
The eligible subjects were randomized using blocked ran-
domization into one of the two groups: treatment group (Ping
On ointment) and placebo group (petroleum jelly). A minor
trace (0.5%) of Ping On ointment was mixed with the petro-
leum jelly to provide somemedicinal smell to the placebo. The
people involved in the randomization and in preparation and
distribution of study articles were independent from the in-
vestigators, and both the investigators and subjects were
blinded as to the treatment allocation. While there were dif-
ferences in the texture, color, and odor of the placebo and
active ointment, the investigators did not see either ointment
at any time and were instructed not to ask any questions re-
garding the ointment used by a subject. The ointment to be
given to participants was sealed in an opaque, tightly sealed
container and then a bag in which no smell could be detected.
The possibility of contamination was minimized by having
the subjects attend their clinic visits separately and being
asked not to bring the ointment to the clinic. The participants
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were also asked not to apply the ointment on the day of
assessment.
During the study period, eligible subjects were advised to
continue any other ongoing treatment such as medication or
splint therapy for the condition at the same level as usual.
They, however, were requested not to commence any other
new intervention. Careful checks of the consumption of an-
algesics weremade. In principle, there should be none, for any
reason. The participants needed to report any medications
taken or any treatment received during the experimental
phase.
Subjects were asked to complete a diary at home daily,
which included pain rating on a self-administrated 100-mm
Visual Analogue Scale (VAS) diary for 7 days before re-
ceiving the experimental or placebo ointment. Then, the Ping
On ointment and petroleum jelly were distributed to the al-
ready allocated subjects by an independent person. The
subjects were asked to complete the daily diary at home
including the VAS, use of oral analgesics, and occurrence of
adverse effects if there were any.
The participants were taught and given a demonstration on
how to rub the ointment over the painful area and then to
massage in a circular motion for 5 minutes twice a day. The
area of application was just on the skin around the TMJ and
affected muscles, which were usually the temporalis and
masseters. Painful lateral andmedial pterygoidmuscles could
not be approached due to anatomical inaccessibility. The
subjects were reviewed every 2 weeks. After 4 weeks of
ointment application, subjects received a final assessment in
the clinic. Subjects were instructed to record whether there
was any adverse effect daily since using the ointment and to
report back to the investigator at the earliest convenience.
Primary outcome
The primary outcome was the efficacy in the treatment of
TMJ and muscle pain as measured by a VAS. Subjects nee-
ded to complete the VAS once daily in the evening for 7 days
as baseline diary of pain, and daily thereafter for 4 weeks of
application of the ointment=control. The VAS consists of a
100-mm line, anchored with the extremes of pain intensity
represented as ‘‘no pain’’ and ‘‘worst pain possible.’’ VAS has
been shown to provide a robust, sensitive, and reproducible
method of measuring pain.14
Secondary outcome
The secondary outcomewas to assess the mandibular func-
tion and the vertical mouth opening, which was the maximal
comfortable mandibular opening measured in millimeters at
the subject’s maximum incisor-to-incisor mouth opening us-
ing a ruler. This measure of mandibular movement was de-
fined as the maximal interincisal distance a subject can open
without experiencing evoked pain. This measure has previ-
ously been shown to be valid and reliable.2,15
Statistical analysis
The data were analyzed using SPSS standard statistical
package (SPSS Statistical Software, Chicago, IL). Homogeneity
of treatment for gender, age, and pain duration was analyzed
by w2 test. Pain diaries collected daily by VAS for 5 weeks
were assessed by two-way analysis of variance and Tukey’s
multiple-comparison tests. Maximum mandibular comfort-
able opening was analyzed with independent samples t tests.
Values are reported as mean 1 standard deviation. All tests
were considered statistically significant at p< 0.05.
The determination of sample size for this study was based
on a postulated improvement treatment effect in 50% of the
active treatment group compared to placebo group.16 A
sample size of 22 per treatment group was calculated a priori
as sufficient to detect this difference with 80% power with an
a level of 0.05.
Results
Sixty-three (63) subjects were invited for screening evalu-
ation at the Orthodontic Clinic, Faculty of Dentistry, the
University of Hong Kong. At the completion of the screening
evaluation, 55 subjects were recruited and 45 of them com-
pleted the study. Of the 10 subjects who did not complete the
study, 5 withdrew from the study due to time constraint and 5
failed to return for follow-up (see Fig. 1 outlining subject
flowchart through the study).
Subject characteristics
No significant differences between the treatment group
and the placebo group were detected with respect to age,
gender, or pain duration (Table 1).
Primary outcome measures:
Efficacy in the pain relief measured by VAS
Both Ping On ointment and placebo groups showed im-
provement in the mean VAS scores for pain intensity. How-
ever, only the Ping On ointment group results showed
statistical significance ( p< 0.001). ThePingOn ointment group
started to show significant symptomatic improvement after
day 15, in comparison with the placebo group, which started
about 1week after applying the ointment. Thismight be due to
the anti-inflammatory and analgesic effect ofPingOn ointment
Assessed for eligibility n= 63 
Excluded n= 8 
Exclusion criteria fulfilled: 
n=7 
Refused to participate: n=1 
Randomized (n= 55) 
Received Ping On Ointment 
       n = 28 
Dropout n = 5 
Reason: 1 due to time 
conflict; 4 had no explanation 
Attended endpoint assessment 
       n = 23 
Analyzed n = 23 
Received placebo 
       n = 27 
Dropout n = 5 
Reason: 2 due to time conflict; 
3 had no explanation 
Attended endpoint assessment 
       n = 22 
Analyzed n = 22 
FIG. 1. Subject flowchart through the study.
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on the affected tissues. Two (2) of the subjects in the Ping On
ointment group showed complete remission of pain at the final
assessment.
Clinically significant pain reduction was defined as de-
crease of pain rating by 50% from the baseline pain rating
during the treatment period.17 In the Ping On ointment
group, the pain ratings reflected by VAS dropped 55% from
the baseline rating after completion of the treatment, which
was considered clinically significant (Fig. 2, Table 2).
Secondary outcome measures: Maximum comfortable
mandibular opening measured in millimeters
Subjects in both the Ping On ointment group and the pla-
cebo group had an increased maximum comfortable mandib-
ular opening at the final visit as measured in millimeters
compared tobaserecords.However,only thePingOnointment
group showed a significant difference ( p< 0.01) (Table 3).
Adverse effects
All the reported adverse effects were mild in severity.
There was no subject dropout due to adverse events. Eye
irritation was among the most commonly reported. One (1)
subject in the Ping On ointment group stopped the treatment
for 3 days due to a burning sensation of the skin (Table 4).
Discussion
The results demonstrated that topical application of Ping
On ointment was more effective than placebo in reducing
pain from TMJ and masticatory muscles, and it reached a
level of statistical significance. Therefore, the results support
the hypothesis that there is significant improvement in pain
relieving in patients receiving Ping On ointment compared
with those receiving petroleum jelly. Consequently, the null
hypothesis can be rejected.
The finding that improvement in pain rating in the Ping
On ointment group was evident after 1 week of application
(started from the 15th day including the first week when no
ointment was applied), suggesting that the topical prepara-
tion has a rapid onset of action. The analgesic effect of Ping
On ointment might be explained by the anti-inflammatory
and anesthetic effect of its active ingredients. Study on the
anti-inflammatory and analgesic effects of essential oils of
eucalyptus showed that they possess neutrophil-dependent
and independent anti-inflammatory activities as well as
central and peripheral analgesic effects.18 Methyl salicylate
(birch oil) is widely available in many over-the-counter an-
algesic preparations because of its anti-inflammatory and
analgesic properties.19 Beeswax, commonly known as prop-
olis, has proved successful in the treatment of chronic
backache and hip pain, as well as fresh injuries of muscles
and tendons.20 The ethanolic extract of propolis also has
profound anti-inflammatory effects on both chronic and
acute inflammation.21 Pain is at times related to ischemia due
to tension or muscle spasm that can be improved by vaso-
Table 1. Subject Baseline Characteristics
(Mean Standard Deviation [SD])
Ping On ointment Placebo
Sample size 23 22
Age (mean SD) years 43.96 (13.127) 47.14 (9.296)
Female:male sex ratio 17:6 15:7
Pain duration
(mean SD) months
29.61 (31.442) 35.82 (31.526)
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FIG. 2. Ping On ointment effect on temporomandibular joint and muscle pain intensity. Pain intensity daily time effect curve
is shown as measured on a 100-mm visual analogue scale (VAS) for Ping On ointment and placebo. Data are expressed as
mean values standard error of the mean. Ping On ointment had significant analgesic effect on pain compared with placebo
starting from day 15 ( p< 0.05). Although there was a trend toward decrease in pain severity in the placebo group, there was
no significant difference detected in this decrease in pain reduction compared to the baseline score.
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dilation, which brings more oxygen to the affected area. This
anti-inflammatory and vasodilative nature of these ingredi-
ents might play a major role in the pain relief.
The speed of onset of pain relief observed in this study
was an unexpected finding. While one can only speculate
about the mechanisms underlying the clinical observations, it
is possible that the active ingredients such as peppermint oil,
menthol, camphor, and aromatic oil provided immediate
analgesic activity, and the repeated application of these
agents contributed to the observed results. Peppermint oil
has been shown to be effective for relaxing and smoothing
muscle and was effective in the treatment of tension and
headache, and may have action on the vascular tissue.22
From previous studies, 10% peppermint oil in ethanol solu-
tion had been shown to alleviate tension-type headache.23
Peppermint has a high menthol content, which has a ubiq-
uitous use in dermatology for its topical anesthetic and an-
algesic effects.24 Menthol has been used since antiquity for
medicinal purposes, but it is only the relatively recent dis-
covery of thermosensitive cation channels in the sensory
nerves that finally provides the answer to how menthol can
elicit the same cool sensation as low temperatures.24 From
previous studies, it was found that menthol caused analgesia
by desensitizing nociceptive C fibers25 and=or by its activa-
tion of TRPM8 and=or inhibition of TRPA1.26 Galeotti et al.27
demonstrated that menthol has a strong dose-dependent
local anesthetic action. In topical use, menthol has been
shown to facilitate the penetration of other drugs through the
epidermis.28 Its ability as a penetration enhancer makes it an
ideal vehicle for topical formulation.24 Camphor is a natu-
rally occurring compound that is used as a major active
ingredient of balms and liniments supplied as topical anal-
gesics. Despite its long history of common medical use, the
underlying molecular mechanism of camphor action is not
understood. Capsaicin and menthol, two other topically
applied agents widely used for similar purposes, are known
to excite and desensitize sensory nerves by acting on two
members of transient receptor potential channel superfamily.
Camphor has been shown to activate them.29 Aromatic oil
was also shown to have analgesic effect in the treatment of
lower back pain.30 Local massage increases the local circu-
lation to increase the transmission of the drug.
Traditional ChineseMedicine recognizes TMDs as a type of
arthromyodynia (Bi syndrome).31 Arthromyodynia is mainly
manifested as body pain, swelling, stiffness, and tendon
spasm.32 The most common type is the anemofrigid-damp
arthralgia, which is caused by the Wind–Cold Damp patho-
gen. Arthralgia, in the theory of TCM, has the meaning of
blockage and obstruction. The blockage of the meridians,
vessels, bones, muscles, tendons, and skin result in the pain.
Thus, the treatment principle is to activate the medians and
collaterals, promote the circulation, and relieve the stagna-
tion. The mechanism is therefore to relieve Wind, concur-
rently disperse Cold, and eliminate Dampness.33 According to
the properties of Chinese medicinal herbs, peppermint34 and
eucalyptus35 have the action of expelling the Wind, and san-
dalwood35 and camphor35 can dry the Dampness and clear
the Cold. Bee wax35 and sandalwood35 promote the circula-
tion of medians and collaterals, while peppermint34 and
camphor35 disperse stagnation.
Movement-evoked pain in mouth opening is a common
measure in TMDs and muscular pain and also had been used
in recent studies of TMDtreatments since thismeasuredirectly
reflects the patient’s jaw function as well as improvements in
signs and symptoms.2,36 For painful TMD conditions, a
minimum of 9-mm increase in mandibular range of motion is
considered to be a clinically significant improvement follow-
ing a therapeutic intervention.37,38 In our finding, subjects in
the Ping On ointment group had significantly greater change
(4.435mm) in the mandibular maximal comfortable opening
relative to the placebo group (0.818mm). However, this has
not achieved the 9-mm standard to be considered as clinically
significant. This might be due to the limited penetration ef-
fect of the topical medicinal ingredients of the ointment to
the tissue and also the limited duration of application.
Table 2. Primary Outcome Measure with Pain
Intensity
Ping On ointment (n¼ 23) Placebo (n¼ 22)
Mean SD Mean SD
Baseline 49.35a 14.44 47.76a 11.88
Week 1 42.48a 14.52 46.92a 13.14
Week 2 31.50b,c 16.30 44.81a,b 12.43
Week 3 25.09c 17.34 42.63a,b 12.84
Week 4 21.93c 18.08 40.81a,b 14.44
Visual analogue scale results were analyzed using two-way
analysis of variance and Tukey’s multiple-comparison tests.
a,b,cGroups identified by different superscripts were significantly
different at p< 0.05.
Two-way analysis of variance revealed that significant differences
( p< 0.001) were observed for the factor ‘‘treatment’’ ( p< 0.001) and
factor ‘‘time’’ ( p< 0.001). The interactions between these two factors
were significant ( p< 0.001).
SD, standard deviation.
Table 3. Ping On Ointment and Placebo Effects
on Maximum Comfortable Mandibular Opening
Following 4 Weeks of Treatment
Mean maximum comfortable mandibular
opening (mm)
Week
Ping On ointment
(n¼ 23)
Placebo
(n¼ 22)
Baseline 31.48 11.457 33.18 12.385
Week 4 35.91 11.453 34.00 12.067
Mean difference 4.435 6.680 0.818 3.404
Significance 0.004a 0.272
(2-tailed)
Values are mean standard deviation.
aPing On ointment group (4.435mm) had significant improvement
with greater change in mandibular movement ( p< 0.01) compared
to placebo group (0.818mm).
Table 4. Incidence of Adverse Events Reported
During the 4-Week Study
Reported adverse
events
Ping On ointment
(n¼ 23)
Placebo
(n¼ 22)
Eye irritation 6 0
Burning sensation 3 0
Itchiness 1 1
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Nevertheless, the improved mandibular mobility observed
seemed correlated with those seen in daily reported pain
intensity at rest. This finding indicated that Ping On ointment
might have effect on reducing both evoked pain and pain at
rest or spontaneous pain.
In this 4-week study, Ping On ointment showed safety and
high tolerability at the recommended doses. No major ad-
verse event was observed or reported. However, eye irritation
and mild burning sensation of the skin seemed to be common
complications of using Ping On ointment. The high incidence
of eye irritation could be explained by the proximity of the
TMJ area to the eyes. The patients should be advised to avoid
applying the ointment too close the eyes. Particular attention
should be paidwhen going to sleep, as it may increase the risk
of having the ointment enter the eyes.
In this study, the subjects were screened by clinical ex-
aminations and self-reported questionnaires. Ideally, the di-
agnosis should be made with a combination of magnetic
resonance imaging or computed tomography.
This study reported the short-term effect of Ping On oint-
ment. The results only applied to the immediate effect of using
Ping On ointment for up to 4 weeks. The sample size of the
present study was rather small. A multicenter study stratify-
ing subjects into those with predominantly muscle pain and
those with joint pain in a long-term follow-up period would
give more conclusive results and information regarding the
long-term benefit of this topical ointment.
Further questions that need to be asked are: What actually
caused the therapeutic effect? Was it the properties of the
ointment or the regular effects of the massage when the oint-
ment was being applied? How do we know that the ointment
did not just provide an effective lubricant formassage like that
shown for other forms of manual therapy? Does it have a
neurophysiologic effect on descending pain inhibitory sys-
tems? All of these are important considerations in future
clinical trials testing the ointment’s effectiveness. Further re-
search is also needed to investigate the effect of the Ping On
ointment on the joint tissue at the biochemical and molecular
levels and to identify the combined effects of different active
ingredients involved.
Nonetheless, the results of this study showed that topical
application of Ping On ointment may be considered for fur-
ther investigation as a potential first-line treatment modality,
before prescribing analgesics, in the management of TMDs. It
is topically applied, safe, reversible, and effective in man-
aging TMDs and masticatory muscle pain.
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